Skip to main content
. 2020 Jan 17;12(1):231. doi: 10.3390/cancers12010231

Table 3.

Association between the copy number (CN) status and gene expression profile of the EGFR, CDK4, MDM4, and PDGFRA genes in GBM.

CN Status
(N. Cases and Percentage)
Gene Expression Profile of GBM
Low/Normal Expression High Expression p-Value
AmpEGFR
(n = 83)
No
(64%)
N. of Cases (%) 28 (53%) 25 (47%)
FC 1.14
(0.22–2.32)
6.93
(2.89–76.74)
<0.001
Yes
(36%)
N. of Cases (%) 7 (23%) 23 (77%)
FC 1.67
(0.06–2.83)
46.02
(7.45–251.94)
<0.001
p-Value 0.10 <0.001 0.01 *
AmpCDK4
(n = 68)
No
(82%)
N. of Cases (%) 4 (7%) 52 (93%)
FC 1.13
(0.58–1.40)
3.27
(1.55–117.40)
<0.001
Yes
(18%)
N. of Cases (%) 1 (8%) 11 (92%)
FC 1.2
(1.2)
10.57
(1.57-89.07)
<0.001
p-Value 1 0.08 0.87 *
AmpMDM4
(n = 68)
No
(91%)
N. of cases (%) 38 (61%) 24 (39%)
FC 0.86
(0.27–1.41)
1.76
(1.46–5.65)
<0.001
Yes
(9%)
N. of cases (%) 2 (33%) 4 (67%)
FC 0.96
(0.55–1.36)
12.09
(1.74–25.23)
<0.001
p-Value 0.85 0.02 0.18 *
AmpPDGFRA
(n = 68)
No
(93%)
N. of Cases (%) 26 (41%) 37 (59%)
FC 0.63
(0.04–1.55)
3.27
(1.71–66.88)
<0.001
Yes
(7%)
N. of Cases (%) 1 (20%) 4 (80%)
FC 0.16
(0.16)
3.34
(2.77–102.47)
<0.001
p-Value 0.25 0.51 0.35 *

CN: copy number; FC: fold change; *: Pearson Chi-Square test for comparison of patient distribution. Results expressed as number of cases (percentage) or as median FC values (range).